Bupropion Tablet, Extended Release
Product Images NDC 65841-780

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion (NDC 65841-780). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

577eda07 Fd4e 494e A769 5338ba679892 02

This is a description of a medication called "BuPROPion Hydrochloride Extended-Release Tablets" that contains 300mg of the active ingredient. The medication is in tablet form and is designed for once-daily use. The tablets are manufactured by the company Zydus and bear the NDC code 65841-780-05. Patients are warned not to take this medication out of the reach of children.*

FDA Label Image

577eda07 Fd4e 494e A769 5338ba679892 03

This is a description of a medication called "buPROPion oo cmeroPon oo 5P Hydrochloride" in an extended-release form. Its usual dosage is one tablet per day. There is a warning not to use it with other medications that contain bupropion hydrochloride, including Zyban®. The medication comes in a container that is resistant to moisture and should be kept out of reach of children. The manufacturer of this medication is Zydus Healthcare, located in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.